Investor Relations


Stock Quote (NASDAQ: PODD)

Price:
43.26
Change:
- 0.67
Day High:
44.12
Day Low:
43.05
Volume:
535,626
4:00 PM ET on Sep 26, 2016
Delayed ~20 min. By eSignal.
Stock price graph
     

Corporate Profile

Insulet Corporation is an innovative medical device company based in Billerica, Massachusetts. It was founded in 2000 with the mission of improving the lives of people with diabetes. Specifically, through its revolutionary OmniPod Insulin Management System, Insulet seeks to expand the use of insulin pump therapy.

Studies have demonstrated the advantages of insulin pump therapy over multiple daily insulin injections (MDI); these advantages include better glycemic control, fewer hypoglycemic events, reduced glycemic variability1 and improved quality of life2. Despite these benefits, most people still choose MDI therapy largely due to the complexity, cost and inconvenience of conventional..More ▼

View all »   RSSRecent Releases

Sep 13, 2016
Insulet Enrolls First Patients in Clinical Trial for its Omnipod® Artificial Pancreas System

Sep 7, 2016
Insulet Announces Pricing of Convertible Senior Notes Due 2021

View all »Events & Presentations

Aug 3, 2016 at 4:30 PM ET
Q2 2016 Insulet Corporation Earnings Conf Call
Webcast Listen to webcast

Mar 7, 2016 at 7:30 AM ET
Raymond James 37th Annual Institutional Investors Conference Presentation
PDF View Presentation  808.2 KB